July 27, 2022 | From the Trenches

You Can’t Do It Alone – The Importance of Riding the Same Bus

From academic research, patent law, business development, to being a CEO, all my experiences have taught me two things. First, one cannot do it all alone (especially in biotech). Second, the biotech ecosystem is unique in a sense that everyone, irrespective of background, shares the same goal: to improve patient lives.

By Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC

July 6, 2022 | LifeSciVC

Surprising Resilience Of Private VC-Backed Biotech Markets

It’s biotech armageddon out there: with massive value destruction across public stocks, it’s clearly the worst market backdrop in over 20 years.

June 29, 2022 | Uncategorized

Atlas Venture’s Recent Leadership & Team Additions

Biotech venture creation is a team endeavor. We work with the best teams in the business. Meet some of our new CEOs and the most recent additions to our investment team in our newsletter.

June 28, 2022 | From the Trenches

This Too Shall Pass

Although I intend to shy away from the cult of celebrity, a recent clip from Tom Hanks resonated with me regarding the current state of the biotech market. As Mr Hanks continues his evolution into that trusted grandfatherly type of statesman, he spoke sagely with a group of peers and juniors reminding them all that “This too shall pass”.

By Robert Clarke, CEO of Kinaset, as part of the From The Trenches feature of LifeSciVC.

June 21, 2022 | From the Trenches

Hacking the Human Cell – How Once ‘Un-druggable’ Proteins Became the New Frontier in Drug Development

White Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system by exploiting its entry points. They don’t use their computers like the rest of us do. While most of us start our workdays by firing up a laptop, clicking a web browser icon and moving through a series of user-friendly, color-coded steps, white hat hackers spend their days looking at black screens strewn with code that seems unintelligible to the untrained eye. It’s as if they are getting behind the screen, peering deep inside the inner workings of the computer where they can unlock secret functions and reprogram conventional behaviors.

By Jonathan Montagu, CEO and founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC.